Larvol Delta - ASLAN-Pharmaceuticals-to-Host-Webcast-on-July-6-2023-to-Discuss-Phase-2b-Topline-Data-From-TREKAD-Trial-Evaluating-Eblasakimab-in-Atopic-Dermatitis

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2023/07/05/2699949/0/en/ASLAN-Pharmaceuticals-to-Host-Webcast-on-July-6-2023-to-Discuss-Phase-2b-Topline-Data-From-TREK-AD-Trial-Evaluating-Eblasakimab-in-Atopic-Dermatitis.html

Jul 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next